Nutra Pharma annual debt-to-assets ratio
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Nutra Pharma Debt-to-Assets Ratio Growth & History (NPHC)
Nutra Pharma's debt-to-assets ratio was 15.67 for fiscal 2025.
View full Nutra Pharma company overviewNutra Pharma annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 15.67 | 1.12 | +7.73% |
| 2024 | 2024-12-31 | 14.55 | 1.05 | +7.74% |
| 2023 | 2023-12-31 | 13.51 | 2.66 | +24.52% |
| 2022 | 2022-12-31 | 10.85 | 0.53 | +5.12% |
| 2021 | 2021-12-31 | 10.32 | −5.70 | −35.60% |
| 2020 | 2020-12-31 | 16.02 | −8.93 | −35.78% |
| 2019 | 2019-12-31 | 24.95 | 15.11 | +153.54% |
| 2018 | 2018-12-31 | 9.84 | 8.09 | +461.95% |
| 2017 | 2017-12-31 | 1.75 | −2.40 | −57.79% |
| 2016 | 2016-12-31 | 4.15 | 3.77 | +995.57% |
| 2015 | 2015-12-31 | 0.38 | −1.02 | −72.89% |
| 2014 | 2014-12-31 | 1.40 | −3.93 | −73.80% |
| 2013 | 2013-12-31 | 5.33 | — | — |
Nutra Pharma quarterly debt-to-assets ratio
Q4.13
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 20.19 | 9.09 | +81.94% |
| Q1 2026 | 2026-03-31 | 16.23 | 4.45 | +37.82% |
| Q4 2025 | 2025-12-31 | 15.67 | 1.12 | +7.73% |
| Q3 2025 | 2025-09-30 | 13.66 | −1.63 | −10.68% |
| Q2 2025 | 2025-06-30 | 11.10 | −2.53 | −18.55% |
| Q1 2025 | 2025-03-31 | 11.78 | — | — |
| Q4 2024 | 2024-12-31 | 14.55 | — | — |
| Q3 2024 | 2024-09-30 | 15.29 | — | — |
| Q2 2024 | 2024-06-30 | 13.62 | — | — |
| Q4 2022 | 2022-12-31 | 10.85 | 0.53 | +5.12% |
| Q3 2022 | 2022-09-30 | 11.42 | 1.38 | +13.74% |
| Q2 2022 | 2022-06-30 | 11.03 | −3.64 | −24.80% |
| Q1 2022 | 2022-03-31 | 9.31 | −14.23 | −60.45% |
| Q4 2021 | 2021-12-31 | 10.32 | −5.70 | −35.60% |
| Q3 2021 | 2021-09-30 | 10.04 | 8.68 | +639.76% |
| Q2 2021 | 2021-06-30 | 14.67 | 13.32 | +987.45% |
| Q1 2021 | 2021-03-31 | 23.55 | 22.33 | +1834.34% |
| Q4 2020 | 2020-12-31 | 16.02 | — | — |
| Q3 2020 | 2020-09-30 | 1.36 | — | — |
| Q2 2020 | 2020-06-30 | 1.35 | — | — |
| Q1 2020 | 2020-03-31 | 1.22 | — | — |
| Q4 2018 | 2018-12-31 | 9.84 | 8.09 | +461.95% |
| Q3 2018 | 2018-09-30 | 2.87 | −2.12 | −42.49% |
| Q2 2018 | 2018-06-30 | 1.86 | −3.83 | −67.34% |
| Q1 2018 | 2018-03-31 | 2.08 | −3.93 | −65.39% |
| Q4 2017 | 2017-12-31 | 1.75 | −2.40 | −57.79% |
| Q3 2017 | 2017-09-30 | 4.99 | 2.57 | +105.85% |
| Q2 2017 | 2017-06-30 | 5.69 | 2.89 | +103.33% |
| Q1 2017 | 2017-03-31 | 6.01 | 1.31 | +27.89% |
| Q4 2016 | 2016-12-31 | 4.15 | 3.77 | +995.57% |
| Q3 2016 | 2016-09-30 | 2.42 | 1.69 | +228.64% |
| Q2 2016 | 2016-06-30 | 2.80 | 2.00 | +248.46% |
| Q1 2016 | 2016-03-31 | 4.70 | 3.80 | +423.86% |
| Q4 2015 | 2015-12-31 | 0.38 | −1.02 | −72.89% |
| Q3 2015 | 2015-09-30 | 0.74 | −0.92 | −55.38% |
| Q2 2015 | 2015-06-30 | 0.80 | 0.38 | +88.11% |
| Q1 2015 | 2015-03-31 | 0.90 | — | — |
| Q4 2014 | 2014-12-31 | 1.40 | −3.93 | −73.80% |
| Q3 2014 | 2014-09-30 | 1.65 | — | — |
| Q2 2014 | 2014-06-30 | 0.43 | — | — |
| Q4 2013 | 2013-12-31 | 5.33 | — | — |
Nutra Pharma debt-to-assets ratio trends
Over the last five fiscal years, Nutra Pharma's debt-to-assets ratio decreased from 16.02 to 15.67, a change of −0.34. The latest reported quarter, Q2 2026, shows 20.19.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nutra Pharma source filings ↗